Advertisement

Topics

Hikma Pharmaceuticals says current year has got off to “an encouraging start”

04:04 EDT 18 May 2018 | Proactive Investors

the FTSE 250-listed generic drugs maker’s CEO Siggi Olafsson, said: "Our efforts to reduce costs across the Group are on track and we continue to focus on enhancing and investing in our pipeline"

Original Article: Hikma Pharmaceuticals says current year has got off to “an encouraging start”

NEXT ARTICLE

More From BioPortfolio on "Hikma Pharmaceuticals says current year has got off to “an encouraging start”"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...